Product Code: ETC13161342 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Prophylactic Vaccines Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Prophylactic Vaccines Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Prophylactic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Prophylactic Vaccines Market - Industry Life Cycle |
3.4 Africa Prophylactic Vaccines Market - Porter's Five Forces |
3.5 Africa Prophylactic Vaccines Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Prophylactic Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 Africa Prophylactic Vaccines Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.8 Africa Prophylactic Vaccines Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.9 Africa Prophylactic Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 Africa Prophylactic Vaccines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Africa Prophylactic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Prophylactic Vaccines Market Trends |
6 Africa Prophylactic Vaccines Market, 2021 - 2031 |
6.1 Africa Prophylactic Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Prophylactic Vaccines Market, Revenues & Volume, By Live/Attenuated Vaccines, 2021 - 2031 |
6.1.3 Africa Prophylactic Vaccines Market, Revenues & Volume, By Inactivated Vaccines, 2021 - 2031 |
6.1.4 Africa Prophylactic Vaccines Market, Revenues & Volume, By Subunit Vaccines, 2021 - 2031 |
6.1.5 Africa Prophylactic Vaccines Market, Revenues & Volume, By Toxoid Vaccines, 2021 - 2031 |
6.1.6 Africa Prophylactic Vaccines Market, Revenues & Volume, By Conjugate Vaccines, 2021 - 2031 |
6.1.7 Africa Prophylactic Vaccines Market, Revenues & Volume, By Recombinant Vector Vaccines, 2021 - 2031 |
6.2 Africa Prophylactic Vaccines Market, Revenues & Volume, By Disease, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Prophylactic Vaccines Market, Revenues & Volume, By Pneumococcal Disease, 2021 - 2031 |
6.2.3 Africa Prophylactic Vaccines Market, Revenues & Volume, By Poliovirus, 2021 - 2031 |
6.2.4 Africa Prophylactic Vaccines Market, Revenues & Volume, By Hepatitis, 2021 - 2031 |
6.2.5 Africa Prophylactic Vaccines Market, Revenues & Volume, By Influenza, 2021 - 2031 |
6.2.6 Africa Prophylactic Vaccines Market, Revenues & Volume, By Measles, 2021 - 2031 |
6.2.7 Africa Prophylactic Vaccines Market, Revenues & Volume, By Mumps, 2021 - 2031 |
6.2.8 Africa Prophylactic Vaccines Market, Revenues & Volume, By Rubella (MMR), 2021 - 2031 |
6.2.9 Africa Prophylactic Vaccines Market, Revenues & Volume, By Varicella, 2021 - 2031 |
6.3 Africa Prophylactic Vaccines Market, Revenues & Volume, By Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Prophylactic Vaccines Market, Revenues & Volume, By Intramuscular Route, 2021 - 2031 |
6.3.3 Africa Prophylactic Vaccines Market, Revenues & Volume, By Subcutaneous Route, 2021 - 2031 |
6.3.4 Africa Prophylactic Vaccines Market, Revenues & Volume, By Oral Route, 2021 - 2031 |
6.3.5 Africa Prophylactic Vaccines Market, Revenues & Volume, By Intravenous Injection, 2021 - 2031 |
6.3.6 Africa Prophylactic Vaccines Market, Revenues & Volume, By Administration Routes, 2021 - 2031 |
6.4 Africa Prophylactic Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Prophylactic Vaccines Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.4.3 Africa Prophylactic Vaccines Market, Revenues & Volume, By Retail Pharmacy and Online Pharmacy, 2021 - 2031 |
6.5 Africa Prophylactic Vaccines Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Africa Prophylactic Vaccines Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.3 Africa Prophylactic Vaccines Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.5.4 Africa Prophylactic Vaccines Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
7 Africa Prophylactic Vaccines Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Prophylactic Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.1 South Africa Prophylactic Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.2 Egypt Prophylactic Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.3 Nigeria Prophylactic Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.4 Rest of Africa Prophylactic Vaccines Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.3 Africa Prophylactic Vaccines Market Revenues & Volume Share, By Disease, 2021 & 2031F |
7.3.1 South Africa Prophylactic Vaccines Market, Revenues & Volume, By Disease, 2021 - 2031 |
7.3.2 Egypt Prophylactic Vaccines Market, Revenues & Volume, By Disease, 2021 - 2031 |
7.3.3 Nigeria Prophylactic Vaccines Market, Revenues & Volume, By Disease, 2021 - 2031 |
7.3.4 Rest of Africa Prophylactic Vaccines Market, Revenues & Volume, By Disease, 2021 - 2031 |
7.4 Africa Prophylactic Vaccines Market, Revenues & Volume, By Administration, 2021 - 2031 |
7.4.1 South Africa Prophylactic Vaccines Market, Revenues & Volume, By Administration, 2021 - 2031 |
7.4.2 Egypt Prophylactic Vaccines Market, Revenues & Volume, By Administration, 2021 - 2031 |
7.4.3 Nigeria Prophylactic Vaccines Market, Revenues & Volume, By Administration, 2021 - 2031 |
7.4.4 Rest of Africa Prophylactic Vaccines Market, Revenues & Volume, By Administration, 2021 - 2031 |
7.5 Africa Prophylactic Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.1 South Africa Prophylactic Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.2 Egypt Prophylactic Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.3 Nigeria Prophylactic Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.4 Rest of Africa Prophylactic Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.6 Africa Prophylactic Vaccines Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.6.1 South Africa Prophylactic Vaccines Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.6.2 Egypt Prophylactic Vaccines Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.6.3 Nigeria Prophylactic Vaccines Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.6.4 Rest of Africa Prophylactic Vaccines Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8 Africa Prophylactic Vaccines Market Key Performance Indicators |
9 Africa Prophylactic Vaccines Market - Export/Import By Countries Assessment |
10 Africa Prophylactic Vaccines Market - Opportunity Assessment |
10.1 Africa Prophylactic Vaccines Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Prophylactic Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
10.3 Africa Prophylactic Vaccines Market Opportunity Assessment, By Disease, 2021 & 2031F |
10.4 Africa Prophylactic Vaccines Market Opportunity Assessment, By Administration, 2021 & 2031F |
10.5 Africa Prophylactic Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10.6 Africa Prophylactic Vaccines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
11 Africa Prophylactic Vaccines Market - Competitive Landscape |
11.1 Africa Prophylactic Vaccines Market Revenue Share, By Companies, 2022 |
11.2 Africa Prophylactic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |